DelMar Pharmaceuticals Inc Share Price Nasdaq
Equities
US2470782077
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 6.82M 538M |
---|---|---|---|---|---|
Net income 2022 | -22M -1.74B | Net income 2023 | -14M -1.11B | EV / Sales 2022 | - |
Net cash position 2022 | 11.78M 930M | Net cash position 2023 | 2.61M 206M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.54
x | P/E ratio 2023 |
-0.43
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.81% |
Latest transcript on DelMar Pharmaceuticals Inc
Managers | Title | Age | Since |
---|---|---|---|
Robert Hoffman
CEO | Chief Executive Officer | 58 | 10/04/18 |
Greg Johnson
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Hoffman
CEO | Chief Executive Officer | 58 | 10/04/18 |
Tamara Favorito
BRD | Director/Board Member | 65 | 28/04/21 |
Laura Douglass
BRD | Director/Board Member | 59 | 25/06/20 |
1st Jan change | Capi. | |
---|---|---|
+7.52% | 113B | |
+11.38% | 106B | |
+0.84% | 22.27B | |
-12.64% | 22.22B | |
-4.50% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+7.77% | 14.29B | |
+37.41% | 12.52B |